MétaCan
Menu
Back to cohort
Record W2788589375 · doi:10.1093/jncics/pky023

Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study

2018· article· en· W2788589375 on OpenAlexafffund
Lieske H. Schrijver, Håkan Olsson, Kelly‐Anne Phillips, Mary Beth Terry, David E. Goldgar, Karin Kast, Christoph Engel, Thea M. Mooij, Julian Adlard, Daniel Barrowdale, Rosemarie Davidson, Rosalind A. Eeles, D. Gareth Evans, Debra Frost, Louise Izatt, Mary Porteous, Lucy Side, Lisa Walker, Pascaline Berthet, Valérie Bonadona, Dominique Leroux, Emmanuelle Mouret‐Fourme, Laurence Venat‐Bouvet, Saundra S. Buys, Melissa C. Southey, Esther M. John, Wendy K. Chung, Mary B. Daly, Anita Bane, Christi J. van Asperen, E. Gómez, Marian J.E. Mourits, Theo A.M. van Os, Marie-José Roos-Blom, Michael L Friedlander, Sue‐Anne McLachlan, Christian F. Singer, Yen Y. Tan, Lenka Foretová, Marie Navrátilová, Anne‐Marie Gerdes, Trinidad Caldés, Jacques Simard, Edith Oláh, Anna Jakubowska, Brita Arver, Ana Osório, Catherine Noguès, Nadine Andrieu, Douglas F. Easton, Flora E. van Leeuwen, John L. Hopper, Roger L. Milne, Antonis C. Antoniou, Matti A. Rookus

Bibliographic record

VenueJNCI Cancer Spectrum · 2018
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversité LavalCentre hospitalier universitaire de QuébecMcMaster UniversityJuravinski Hospital
FundersNational Cancer InstituteNarodowe Centrum Badań i RozwojuNational Institutes of HealthInstitut Claudius RegaudFreistaat SachsenMinistero dello Sviluppo EconomicoNational Health and Medical Research CouncilInstitut National Du CancerDeutsche KrebshilfeMedizinische Universität WienMedical Research CouncilLeids Universitair Medisch CentrumRadboud Universitair Medisch CentrumFondation de FranceOdense UniversitetshospitalRijksuniversiteit GroningenMinisterio de Economía y CompetitividadNederlandse Organisatie voor Wetenschappelijk OnderzoekCancer AustraliaUniversität WienLunds UniversitetUniversiteit MaastrichtInstitut Gustave-RoussyVrije Universiteit AmsterdamInstituto de Salud Carlos IIIRadboud UniversiteitCancer Research UKGovernment of CanadaHungarian Scientific Research FundFondation du cancer du sein du QuébecEuropean Regional Development FundMinisterstvo Školství, Mládeže a TělovýchovyNational Breast Cancer FoundationMinistère du Développement Économique, de l’Innovation et de l’ExportationNational Institute for Health and Care ResearchGenome CanadaMaastricht Universitair Medisch CentrumEuropean CommissionCanadian Institutes of Health ResearchFundación Mutua MadrileñaRoyal Marsden NHS Foundation TrustUniversiteit LeidenDeutsches Krebsforschungszentrum
KeywordsMedicineRetrospective cohort studyProspective cohort studyHazard ratioBreast cancerProportional hazards modelCohort studyInternal medicineRelative riskConfidence intervalGynecologyObstetricsOncologyCancer

Abstract

fetched live from OpenAlex

Abstract Background For BRCA1 and BRCA2 mutation carriers, the association between oral contraceptive preparation (OCP) use and breast cancer (BC) risk is still unclear. Methods Breast camcer risk associations were estimated from OCP data on 6030 BRCA1 and 3809 BRCA2 mutation carriers using age-dependent Cox regression, stratified by study and birth cohort. Prospective, left-truncated retrospective and full-cohort retrospective analyses were performed. Results For BRCA1 mutation carriers, OCP use was not associated with BC risk in prospective analyses (hazard ratio [HR] = 1.08, 95% confidence interval [CI] = 0.75 to 1.56), but in the left-truncated and full-cohort retrospective analyses, risks were increased by 26% (95% CI = 6% to 51%) and 39% (95% CI = 23% to 58%), respectively. For BRCA2 mutation carriers, OCP use was associated with BC risk in prospective analyses (HR = 1.75, 95% CI = 1.03 to 2.97), but retrospective analyses were inconsistent (left-truncated: HR = 1.06, 95% CI = 0.85 to 1.33; full cohort: HR = 1.52, 95% CI = 1.28 to 1.81). There was evidence of increasing risk with duration of use, especially before the first full-term pregnancy (BRCA1: both retrospective analyses, P < .001 and P = .001, respectively; BRCA2: full retrospective analysis, P = .002). Conclusions Prospective analyses did not show that past use of OCP is associated with an increased BC risk for BRCA1 mutation carriers in young middle-aged women (40–50 years). For BRCA2 mutation carriers, a causal association is also not likely at those ages. Findings between retrospective and prospective analyses were inconsistent and could be due to survival bias or a true association for younger women who were underrepresented in the prospective cohort. Given the uncertain safety of long-term OCP use for BRCA1/2 mutation carriers, indications other than contraception should be avoided and nonhormonal contraceptive methods should be discussed.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.012
Threshold uncertainty score0.025

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.004
Meta-epidemiology (narrow)0.0000.001
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.318
Teacher spread0.303 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations61
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueJNCI Cancer SpectrumSame topicBRCA gene mutations in cancerFrench-language works237,207